|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
How important is surrogate consent for stroke research?
|
18753472 |
2008 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography.
|
18346647 |
2008 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
|
18753474 |
2008 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study.
|
18560214 |
2008 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
How important is surrogate consent for stroke research?
|
18753472 |
2008 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey.
|
17903947 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Intravenous thrombolysis for acute ischemic stroke: the phase IV data.
|
17903870 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey.
|
17903947 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
The Interventional Management of Stroke (IMS) II Study.
|
17525387 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Intravenous thrombolysis for acute ischemic stroke: the phase IV data.
|
17903870 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
The Interventional Management of Stroke (IMS) II Study.
|
17525387 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
|
16809570 |
2006 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Argatroban tPA stroke study: study design and results in the first treated cohort.
|
16908730 |
2006 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
|
16809570 |
2006 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
[Treatment with intravenous rt-PA in a general hospital context: A review of the Saint-Jean Hospital experience from Perpignan, France].
|
17086147 |
2006 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
[Treatment with intravenous rt-PA in a general hospital context: A review of the Saint-Jean Hospital experience from Perpignan, France].
|
17086147 |
2006 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Argatroban tPA stroke study: study design and results in the first treated cohort.
|
16908730 |
2006 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
|
16126134 |
2005 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Single center, databank-based observational study on 120 consecutive patients with i. v. alteplase for acute stroke.
|
16184341 |
2005 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Single center, databank-based observational study on 120 consecutive patients with i. v. alteplase for acute stroke.
|
16184341 |
2005 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
|
16126134 |
2005 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?
|
15087567 |
2004 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke.
|
14657446 |
2004 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
|
14986460 |
2004 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
|
14986460 |
2004 |